about
Surgical site infections following short-term radiotherapy and total mesorectal excision: results of a randomized study examining the role of gentamicin collagen implant in rectal cancer surgery.Aortoesophageal fistula--rare complication after esophagogastrectomy, due to cancer.Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer.The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study.Pancreatic Metastases of Rectal Cancer-Case Report and Literature Review.Conventional cytology vs. immunocytochemistry of intraoperative peritoneal washes in gastric cancer patients subjected to gastrectomy, clinical correlates and association with overall survival.Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies.Preservation of duodenal passage as a determinant of short- and long-term quality of life in gastric cancer patients after total gastrectomy.P-095MSCMCC gastric cancer cohort: indirect comparison between adjuvant chemoradiation and perioperative chemotherapy in gastric cancer patients in a referral site.Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor XenograftsSplenic artery aneurysm bleeding via the ampulla of VaterThe risk of anastomotic leakage after anterior resection: retrospective analysis of 501 rectal cancer patients operated without protective stomaThe gentamicin-collagen implant and the risk of distant metastases of rectal cancer following short-course radiotherapy and curative resection: the long-term outcomes of a randomized studyPembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
P50
Q34288639-9577058F-C6FA-4FCA-8F59-89FF93190009Q38134668-69E54A77-B1BA-48FF-B1C8-099A1D949190Q41030204-073645F1-1483-4A9C-9B9F-F39DB49B2C8BQ41691664-97587FE8-C130-47E6-A8EB-D2625D9EEBB8Q48126385-6B4E804C-3D74-49BA-9558-4DB807075982Q49349026-725A87BC-0AF0-42D9-93D2-29EC2B6BC76EQ50042838-F2A9CF38-4D0C-4B80-83D6-EC6318A6DC61Q53345647-D949068D-4CCC-4459-953F-760A43323EDCQ54264526-B404FC36-FAFF-47B9-89EA-06C1B0CF40E2Q60945933-E84587C0-DA8E-46EE-BE95-402015EAD0B3Q86227650-63671F47-4556-4EDB-AE4C-F1E733E21E93Q88327160-046EB24E-8176-4A6E-A704-45E0496CAF26Q88361759-401CC58A-44D4-4172-9221-99CB78FE2B5BQ89029141-6D17A1C4-F99D-4162-B8B7-0A01AA41E66F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Tomasz Olesiński
@en
Tomasz Olesiński
@nl
type
label
Tomasz Olesiński
@en
Tomasz Olesiński
@nl
prefLabel
Tomasz Olesiński
@en
Tomasz Olesiński
@nl
P31
P496
0000-0001-6492-4331